EVG

Evgen Pharma Plc

Living with MS and Remaining Positive

Living with multiple sclerosis (MS) could be compared to having an annoying house guest that never leaves. At first you can tolerate them, but soon your nerves and resilience wear

Evgen Pharma Plc

Evgen Pharma plc AGM Statement

Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its Annual General Meeting later today in Manchester. At

Hardman & Co

Evgen Pharma 2018, a pivotal year

Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways

Evgen Pharma Plc

Hardman & Co Research: Evgen Pharma PLC

2018, a pivotal year EVG is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways involved